Clinical Outcomes

FDA Approves First Blood Test for Early Alzheimer’s Diagnosis in Symptomatic Adults

The test measures specific protein ratios in blood plasma, enabling earlier and less invasive detection of Alzheimer’s when used alongside other diagnostic tools.